NASDAQ · RETAIL-DRUG STORES AND PROPRIETARY STORES · SMALL CAP
111, Inc. YI
10 fiscal years on record · CNY · FY2025 reported
SEC FILINGS ONLY
Revenue · FY2025
¥12.6B
▼ 12.8% vs FY2024
EPS · FY25
¥-0.38
Dividend / sh · FY25
—
Payout · FY25
—
ROE · FY25
—
Net margin · FY25
-0.2%
Dividend coverage
—
Advertisement
AdSense · Leaderboard 728×90320×100
Result
CNY 12.6B
Revenue, FY2025 · full 10-year series below
Revenue
Net income
The company lost 0 cents on every revenue dollar this year.
Per share
CNY -0.38
Diluted EPS, FY2025
EPS
The company pays no cash dividend.
Profitability
—
Return on equity, FY2025
ROE
Operating margin-0.0%
Net margin-0.2%
Return on assets-0.9%
Returned to shareholders
—
returned in FY2025 · dividends + net buybacks
Dividends paid—
Net buybacks—
Share of profit—
Consecutive raises—
Growth
+8.9% a year
revenue, compounded over five years
CAGR
3 yrs
5 yrs
10 yrs
15 yrs
Revenue
−2.4%
+8.9%
Compound annual rates per period — left blank where the series crosses a loss.
Share base
—
Shares outstanding, FY2025
Change, 5 years—
Change, 10 years—
A share split breaks the comparison across the period, so we leave it out.
Advertisement
AdSense · Leaderboard 728×90300×250
Balance sheet
CNY 2.2B
total assets, end of FY2025
Total assetsCNY 2.2B
EquityCNY -702.2M
CashCNY 511.0M
Gross debtCNY 187.6M
Net debtCNY -323.3M
Current ratio1.09×
The company holds more cash than debt.
History
10 fiscal years
Every figure from documents filed with the SEC · CNY
Metric
2025
2024
2023
2022
2021
2020
2019
2018
2017
2016
Revenue ¥B
12.6
14.4
14.9
13.5
12.4
8.2
4.0
1.8
1.0
0.9
Operating income ¥B
−0.0
0.0
−0.4
−0.4
−0.6
−0.5
−0.5
−0.4
−0.3
−0.4
EBITDA ¥B
0.0
0.0
−0.3
−0.3
−0.6
−0.5
−0.5
−0.4
−0.2
−0.4
Income tax ¥B
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
·
·
Net income ¥B
−0.0
−0.0
−0.4
−0.4
−0.6
−0.5
−0.5
−0.4
−0.2
−0.4
EPS, diluted ¥
−0.38
−0.38
−2.33
−2.50
−4.04
−2.77
−3.05
−3.82
−3.45
−5.81
Dividend / sh ¥
·
·
·
·
·
·
·
·
·
·
Payout %
·
·
·
·
·
·
·
·
·
·
ROE %
·
·
·
·
−674.7
−82.4
−50.2
−274.7
·
·
Shares out B
·
·
·
·
·
·
·
·
·
0.07
Slide the table for earlier years · "·" marks figures not disclosed in the filing for that year.
How we verifyAUDITED
35 of 37
checks passed before publication
EPS recomputationBalance-sheet identityGross profitBalance-sheet liquidity
Every figure was compared against the original statement: 0 failures and 2 presentation gaps.
What we don’t show
We’d rather say what’s missing than fill the gap with an estimate.
P/E rationeeds a market quote — not yet licensed
Market capitalizationneeds a market quote — not yet licensed
Dividend yieldneeds a market quote — not yet licensed
Price-to-bookneeds a market quote — not yet licensed